טוען...
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
The rapid advancement of genome editing technologies has opened up new possibilities in the field of medicine. Nuclease-based techniques such as the CRISPR/Cas9 system are now used to target genetically linked disorders that were previously hard-to-treat. The CRISPR/Cas9 gene editing approach wields...
שמור ב:
| הוצא לאור ב: | J Mol Med (Berl) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7220873/ https://ncbi.nlm.nih.gov/pubmed/32198625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-020-01893-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|